TKB Critical Technologies 1 (NASDAQ:USCT) announced that it has postponed its extension vote to Friday, January 27 at 4:00 p.m. ET.
The special meeting, originally scheduled for yesterday, is being held to vote on an amendment to extend TKB’s completion deadline from January 29 to June 29.
The SPAC recently entered into a definitive agreement to combine with vehicle data tracker Wejo (NASDAQ:WEJO) on January 10. As you may recall, Wejo already completed a SPAC transaction with Virtuoso Acquisition Corp. in November 2021, marking the target company’s 2nd SPAC deal.
Manchester, UK-based Wejo has developed a data analysis suite based on tracking connected cars for a wide array of clients seeking predictive intelligence of vehicle ownership, traffic flows and more.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...